2013
DOI: 10.1016/s1470-2045(13)70497-2
|View full text |Cite
|
Sign up to set email alerts
|

Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

19
494
1
47

Year Published

2014
2014
2022
2022

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 676 publications
(562 citation statements)
references
References 30 publications
19
494
1
47
Order By: Relevance
“…Two large phase 3 trials, the Intraoperative radiotherapy with electrons (ELIOT) trial and the TARGIT trial, compared WBI with IORT PBI using either electron beam (ELIOT) 21 or low-energy x-rays (Intrabeam device, TARGIT). 22 Both trials reported increased risk of IBTR after IORT.…”
Section: Clinical Trialsmentioning
confidence: 99%
“…Two large phase 3 trials, the Intraoperative radiotherapy with electrons (ELIOT) trial and the TARGIT trial, compared WBI with IORT PBI using either electron beam (ELIOT) 21 or low-energy x-rays (Intrabeam device, TARGIT). 22 Both trials reported increased risk of IBTR after IORT.…”
Section: Clinical Trialsmentioning
confidence: 99%
“…Полученные данные являются еще одним клиническим доказательством безопасности использования внутритканевой мультикатетерной бра-хитерапии для проведения APBI у больных РМЖ низ-кого риска после органосохраняющего лечения [25].…”
Section: опухоли женской репродуктивной системы Tumors Of Female Reprunclassified
“…The use of IORT should decrease the exposure of other tissues like skin, soft tissue, heart, and lung to the damaging effects of radiation. When 21 Gy IORT is compared to 50 Gy fractioned external beam radiation therapy (EBRT) there is a 4.8% absolute increased risk of recurrence but no change in mortality [6]. In those patients at high risk for recurrence, boost IORT with a lower dose can precede EBRT.…”
Section: Introductionmentioning
confidence: 99%